MII IG Kerndatensatz-Modul Seltene Erkrankungen
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide Seltene Erkrankungen (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
English
status: Completed
category: Therapeutic procedure
code: Gentherapie mit Onasemnogene abeparvovec (Zolgensma)
performed: 2024-07-29
reasonReference: Condition Spinal muscular atrophy, type I
note:
Gentherapeutikum ohne Komplikationen verabreicht, vorherige Gabe von Prednisolon